Deep Brain Stimulation in Parkinson’s Disease Market Share, Growth, Statistics, – GroundAlerts.com

Related Articles:

• DBS: location, location, location December 15, 2019   Deep brain stimulation (or DBS) represents a well established treatment option for individuals with Parkinson’s who no longer respond to standard therapies. It involves tiny electrodes being embedded in the brain and they modulate populations of neurons that have become dysfunctional. The results of the DBS procedure can be “miraculous” for some individuals – reducing tremors and significantly improving…
• Deep Brain Stimulation for Parkinson’s - An Update February 1, 2019 (Guest post by Dr. Eric Rhoden, PT, DPT)Until recently deep brain stimulation (DBS) for Parkinson’s Disease has been a monopolized industry run and operated by Medtronic, who has produced an amazing device that has changed countless lives. However, technology has developed at a rapid pace over the last year, and now there are more options to be aware of when…
• Deep Brain Stimulation for Parkinson’s - An Update February 1, 2019 (Guest post by Dr. Eric Rhoden, PT, DPT)Until recently deep brain stimulation (DBS) for Parkinson’s Disease has been a monopolized industry run and operated by Medtronic, who has produced an amazing device that has changed countless lives. However, technology has developed at a rapid pace over the last year, and now there are more options to be aware of when…
• Deep Brain Stimulation for Parkinson’s - An Update February 1, 2019 (Guest post by Dr. Eric Rhoden, PT, DPT)Until recently deep brain stimulation (DBS) for Parkinson’s Disease has been a monopolized industry run and operated by Medtronic, who has produced an amazing device that has changed countless lives. However, technology has developed at a rapid pace over the last year, and now there are more options to be aware of when…
• Deep Brain Stimulation for Parkinson’s - An Update February 1, 2019 (Guest post by Dr. Eric Rhoden, PT, DPT)Until recently deep brain stimulation (DBS) for Parkinson’s Disease has been a monopolized industry run and operated by Medtronic, who has produced an amazing device that has changed countless lives. However, technology has developed at a rapid pace over the last year, and now there are more options to be aware of when…
• Deep Brain Stimulation for Parkinson’s - An Update February 1, 2019 (Guest post by Dr. Eric Rhoden, PT, DPT)Until recently deep brain stimulation (DBS) for Parkinson’s Disease has been a monopolized industry run and operated by Medtronic, who has produced an amazing device that has changed countless lives. However, technology has developed at a rapid pace over the last year, and now there are more options to be aware of when…
• Frontotemporal Dementia and Parkinson's Disease Market 2020 In-Depth Analysis of - GroundAlerts.com December 29, 2020 Frontotemporal Dementia and Parkinson's Disease Market 2020 In-Depth Analysis of  GroundAlerts.com
• Monthly Research Review – December 2020 December 31, 2020   At the end of each month the SoPD writes a post which provides an overview of some of the major pieces of Parkinson’s-related research that were made available during December 2020. The post is divided into seven parts based on the type of research: Basic biology Disease mechanism Clinical research New clinical trials Clinical trial news Conferences/lectures Other news…
• Deep Brain Stimulation: The Answer to Chronic Pain? January 15, 2021 Chronic pain affects 1 in every 4 adults in the United States, many of whom are resistant to pharmacotherapy.1 It is a significant burden to both individuals and healthcare systems, affecting mental health, cognitive function, and promoting opioid dependency.2 However, researchers are hot on the heels of discovering new ways to treat the condition — including via deep brain stimulation…
• Monthly Research Review – September 2019 September 30, 2019   At the end of each month the SoPD writes a post which provides an overview of some of the major pieces of Parkinson’s-related research that were made available during September 2019. The post is divided into seven parts based on the type of research: Basic biology Disease mechanism Clinical research New clinical trials Clinical trial news Other news Review…
• Monthly research review: February 2020 February 29, 2020   At the end of each month the SoPD writes a post which provides an overview of some of the major pieces of Parkinson’s-related research that were made available during February 2020. The post is divided into seven parts based on the type of research: Basic biology Disease mechanism Clinical research New clinical trials Clinical trial news Other news Review…
• Deep Brain Stimulation for Parkinson’s Disease: The Past and What the Future Holds March 23, 2018 Despite being used for the past 30 years to treat chronic neurological diseases, including Parkinson’s disease (PD), deep brain stimulation (DBS) “remains a fascinating puzzle to scientists, physicians, and engineers,” the lead author of a new review study said. Challenges the technique presents for both clinicians and engineers include the design of novel, more efficient DBS therapies, the existence of redundancy…
• [Webinar Recording] Davis Phinney Foundation Presents a Virtual DBS Forum May 1, 2020 For many living with Parkinson’s, DBS has the power to reduce or eliminate OFF times, reduce the frequency and dose of medications, and dramatically improve quality of life.  In this webinar, we touched on the what, when, why, how, and more of DBS from movement disorder specialists who recommend it, surgeons who perform it, companies that make the devices, and…
• TGF-beta: The Parkinson’s superfamily? December 12, 2020 # # # # A lot of Parkinson’s research has focused on a neurotrophic factor called glial cell-derived neurotrophic factor (or GDNF). But GDNF only represents a small fraction of a much larger class of neurotrophic factors, called the Transforming growth factor-β (TGF-β) superfamily. Recently, researchers have been investigating some of the other TGF-β family members in preclinical models of…
• Late-stage Patients Show Benefit with Deep Brain Stimulation, Small Study Finds June 4, 2020 Most people with late-stage Parkinson’s disease showed benefit from continued treatment with subthalamic deep brain stimulation (STN-DBS) in a small study in Italy. The researchers also provided an algorithm intended to help guide treatment decisions for those with late-stage disease. Their study, “Should We Consider Deep Brain Stimulation Discontinuation in Late‐Stage Parkinson’s Disease?” was published in the journal Movement Disorders. STN-DBS…
• 2019: Year in review December 31, 2019   In this end-of-year post, we review the Parkinson’s research that caught our attention at SoPD HQ in 2019. Month-by-month we will briefly discuss some of the major pieces of research/announcements that have defined the year and advanced our understanding of Parkinson’s. The list is based on nothing more than the author’s personal opinion – apologies to any researchers who…
• Deep Brain Stimulation for Parkinson’s – A Virtual Forum May 7, 2020     For many living with Parkinson’s, DBS has the power to reduce or eliminate OFF times, reduce the frequency and dose of medications, and dramatically improve quality of life.  In this podcast, learn the what, when, why, how, and more of DBS from movement disorder specialists who recommend it, surgeons who perform it, companies that make the devices, and…
• Levels of glial cell line-derived neurotrophic factor are decreased, but fibroblast growth factor 2 and cerebral dopamine neurotrophic factor are increased in the hippocampus in parkinson's disease. April 30, 2019 Related ArticlesLevels of glial cell line-derived neurotrophic factor are decreased, but fibroblast growth factor 2 and cerebral dopamine neurotrophic factor are increased in the hippocampus in parkinson's disease. Brain Pathol. 2019 Apr 29;: Authors: Virachit S, Mathews KJ, Cottam V, Werry E, Galli E, Rappou E, Lindholm P, Saarma M, Halliday GM, Shannon Weickert C, Double KL Abstract Growth factors…
• Deep brain stimulation has state-dependent effects on motor connectivity in Parkinson's disease. June 21, 2019 Deep brain stimulation has state-dependent effects on motor connectivity in Parkinson's disease. Brain. 2019 Jun 20;: Authors: Kahan J, Mancini L, Flandin G, White M, Papadaki A, Thornton J, Yousry T, Zrinzo L, Hariz M, Limousin P, Friston K, Foltynie T Abstract Subthalamic nucleus deep brain stimulation is an effective treatment for advanced Parkinson's disease; however, its therapeutic mechanism is…
• Webinar Recording: The What, When, Why & How of Deep Brain Stimulation with Dr. Kara Beasley April 23, 2019 Deep Brain Stimulation (DBS) has the potential to increase your quality of life in a significant way; however, it’s not the right treatment for everyone. We recently hosted a webinar all about DBS when we talked about what it is, when to do it, how it works and how it can help you live well with Parkinson’s.  To get access…
• Global Parkinson’s Disease Therapeutics Market Will Reach to USD 5.28 Billion By 2025: Zion Market Research - Yahoo Finance June 10, 2019 Global Parkinson’s Disease Therapeutics Market Will Reach to USD 5.28 Billion By 2025: Zion Market Research  Yahoo FinanceGlobal Parkinson's Disease Therapeutics Market Expected to Surpass USD 4.31 Billion by 2023 ZMR Report  B2B News UpdatesGlobal Parkinsons disease Drug Production Market Share, Revenue, and Average Price by Manufacturers Shared in a Latest Research Report  Market Research PublisherParkinson’s Disease Treatment Market 2019 – Industry Demand,…
• Neurofeedback System Lets Patients Control Brainwaves Linked to Movement, Researchers Say December 21, 2018 Parkinson’s disease patients voluntarily controlled brainwaves associated with motor symptoms using a neurofeedback system, according to new research. These findings have implications for how to best harness brain activity and deep brain stimulation to treat Parkinson’s disease symptoms. The study, “Real-time neurofeedback to modulate β-band power in the subthalamic nucleus in Parkinson’s disease patients,” was published in eNeuro. Many studies…